Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2018

01-12-2018 | Original article

Expression of β-catenin in regenerating renal tubules of cisplatin-induced kidney failure in rats

Authors: Naomi Terada, Mohammad Rabiul Karim, Takeshi Izawa, Mitsuru Kuwamura, Jyoji Yamate

Published in: Clinical and Experimental Nephrology | Issue 6/2018

Login to get access

Abstract

Background

β-Catenin is a multi-functional protein involved in nephrogenesis and also plays important roles in renal injury. Here, the expression of β-catenin was investigated in the proximal renal tubular epithelial cells in cisplatin (CDDP)-induced acute kidney injury (AKI) and chronic kidney injury (CKI), because CDDP-induced renal lesions were characterized by proximal renal tubular epithelial degeneration/regeneration and subsequent interstitial fibrosis.

Methods

F344 rats were treated with CDDP. The expression of β-catenin and proliferative (Ki67) or fibrogenic [vimentin, α-smooth action (α-SMA)] markers was analyzed by immunolabeling.

Results

β-Catenin, vimentin and Ki67 were not seen in the proximal renal tubules of control rats. Interestingly, in CDDP-induced AKI, the regenerating proximal renal tubular epithelial cells reacting strongly with Ki67 expressed membranous or cytoplasmic β-catenin and also showed a positive reaction to vimentin but not to α-SMA. In CDDP-induced CKI, the epithelial cells of abnormally dilated or atrophied renal tubules did not react to β-catenin or Ki67, but showed positive reactions to vimentin and α-SMA. β-Catenin mRNAs were significantly increased in AKI and significantly decreased in CKI.

Conclusion

Newly expressed β-catenin in the proximal renal tubules after AKI may participate in functional regeneration. In CKI, epithelial cells of abnormal renal tubules did not express β-catenin but reacted to vimentin, and α-SMA might indicate the epithelial–mesenchymal transition (EMT) formation, because α-SMA is usually expressed in myofibroblasts forming via EMT. The presence or absence of β-catenin expression would become a marker for the EMT phenomenon in progressive renal fibrosis.
Literature
1.
go back to reference MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26.CrossRef MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26.CrossRef
3.
go back to reference Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469–80.CrossRef Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469–80.CrossRef
4.
go back to reference Park JS, Valerius MT, McMahon AP. Wnt/β-catenin signaling regulates nephron induction during mouse kidney development. Development. 2007;134:2533–39.CrossRef Park JS, Valerius MT, McMahon AP. Wnt/β-catenin signaling regulates nephron induction during mouse kidney development. Development. 2007;134:2533–39.CrossRef
5.
go back to reference He W, Dai C, Li Y, et al. Wnt/β-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–76.CrossRef He W, Dai C, Li Y, et al. Wnt/β-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009;20:765–76.CrossRef
6.
go back to reference Zhou D, Li Y, Lin L, et al. Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int. 2012;82:537–47.CrossRef Zhou D, Li Y, Lin L, et al. Tubule-specific ablation of endogenous beta-catenin aggravates acute kidney injury in mice. Kidney Int. 2012;82:537–47.CrossRef
7.
go back to reference Xiao L, Zhou D, Tan RJ, et al. Sustained activation of Wnt/β-catenin signaling drives AKI to CKD progression. J Am Soc Nephrol. 2016;27:1727–40.CrossRef Xiao L, Zhou D, Tan RJ, et al. Sustained activation of Wnt/β-catenin signaling drives AKI to CKD progression. J Am Soc Nephrol. 2016;27:1727–40.CrossRef
8.
go back to reference Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc. 2002;35:68–80.CrossRef Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc. 2002;35:68–80.CrossRef
9.
go back to reference Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85–97.CrossRef Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85–97.CrossRef
10.
go back to reference Ide M, Yamate J, Kuwamura M, et al. Immunohistochemical analysis of macrophages and myofibroblasts appearing in hepatic and renal fibrosis of dogs. J Comp Patho. 2001;124:60 – 9.CrossRef Ide M, Yamate J, Kuwamura M, et al. Immunohistochemical analysis of macrophages and myofibroblasts appearing in hepatic and renal fibrosis of dogs. J Comp Patho. 2001;124:60 – 9.CrossRef
11.
go back to reference Kuwahara Y, Ohba Y, Kitoh K, et al. Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract. 2006;47:446–50.CrossRef Kuwahara Y, Ohba Y, Kitoh K, et al. Association of laboratory data and death within one month in cats with chronic renal failure. J Small Anim Pract. 2006;47:446–50.CrossRef
12.
go back to reference Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRef Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.CrossRef
13.
go back to reference Yamate J, Okado A, Kuwamura M, et al. Immunohistochemical analysis of macrophages, myofibroblasts, and transforming growth factor-β localization during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction. Toxicol Pathol. 1998;26:793–801.CrossRef Yamate J, Okado A, Kuwamura M, et al. Immunohistochemical analysis of macrophages, myofibroblasts, and transforming growth factor-β localization during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction. Toxicol Pathol. 1998;26:793–801.CrossRef
14.
go back to reference Yamate J, Sato K, Ide M, et al. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol. 2002;39:322 – 33.CrossRef Yamate J, Sato K, Ide M, et al. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol. 2002;39:322 – 33.CrossRef
15.
go back to reference Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180:1340–55.CrossRef Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180:1340–55.CrossRef
16.
go back to reference Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol. 2011;38:467–73.CrossRef Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol. 2011;38:467–73.CrossRef
17.
go back to reference Smith SW, Chand S, Savage CO. Biology of the renal pericyte. Nephrol Dial Transplant. 2012;27:2149–55.CrossRef Smith SW, Chand S, Savage CO. Biology of the renal pericyte. Nephrol Dial Transplant. 2012;27:2149–55.CrossRef
18.
go back to reference LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19:1047–53.CrossRef LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19:1047–53.CrossRef
21.
go back to reference Yamate J, Sato K, Machida Y, et al. Cisplatin-induced rat renal interstitial fibrosis; a possible pathogenesis based on the data. J Toxicol Pathol. 2000;13:237–47.CrossRef Yamate J, Sato K, Machida Y, et al. Cisplatin-induced rat renal interstitial fibrosis; a possible pathogenesis based on the data. J Toxicol Pathol. 2000;13:237–47.CrossRef
22.
go back to reference Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2:2490–518.CrossRef Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2:2490–518.CrossRef
23.
go back to reference Yamamoto E, Izawa T, Juniantito V, et al. Relationship of cell proliferating marker expressions with PGE2 receptors in regenerating rat renal tubules after cisplatin injection. J Toxicol Pathol. 2010;23:271–75.CrossRef Yamamoto E, Izawa T, Juniantito V, et al. Relationship of cell proliferating marker expressions with PGE2 receptors in regenerating rat renal tubules after cisplatin injection. J Toxicol Pathol. 2010;23:271–75.CrossRef
24.
go back to reference Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol. 2003;14:S55–61.CrossRef Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol. 2003;14:S55–61.CrossRef
25.
go back to reference Terada N, Karim MR. Izawa T, et al. Immunolocalization of β-catenin, E-cadherin and N-cadherin in neonate and adult rat kidney. J Vet Med Sec. 2017;79:1785–90.CrossRef Terada N, Karim MR. Izawa T, et al. Immunolocalization of β-catenin, E-cadherin and N-cadherin in neonate and adult rat kidney. J Vet Med Sec. 2017;79:1785–90.CrossRef
26.
go back to reference Smeets B, Boor P, Dijkman H, et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol. 2012;229:645–69.CrossRef Smeets B, Boor P, Dijkman H, et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol. 2012;229:645–69.CrossRef
27.
go back to reference Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem. 2003;51:1681–88.CrossRef Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem. 2003;51:1681–88.CrossRef
28.
go back to reference Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol. 2003;15:158 – 63.CrossRef Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol. 2003;15:158 – 63.CrossRef
29.
go back to reference Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 1994;372:679–83.CrossRef Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 1994;372:679–83.CrossRef
30.
go back to reference Terada Y, Tanaka H, Okado T, et al. Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003;14:1223–33.CrossRef Terada Y, Tanaka H, Okado T, et al. Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol. 2003;14:1223–33.CrossRef
31.
go back to reference Wang Z, Havasi A, Gall JM, et al. Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. J Am Soc Nephrol. 2009;20:1919–28.CrossRef Wang Z, Havasi A, Gall JM, et al. Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax. J Am Soc Nephrol. 2009;20:1919–28.CrossRef
32.
go back to reference Bernard P, Fleming A, Lacombe A, et al. Wnt4 inhibits beta-catenin/TCF signalling by redirecting beta-catenin to the cell membrane. Biol Cell. 2008;100:167–77.CrossRef Bernard P, Fleming A, Lacombe A, et al. Wnt4 inhibits beta-catenin/TCF signalling by redirecting beta-catenin to the cell membrane. Biol Cell. 2008;100:167–77.CrossRef
33.
go back to reference Brossa A, Papadimitriou E, Collino F, et al. Role of CD133 molecule in Wnt response and renal repair. Stem Cells Transl Med. 2018;7:283–94.CrossRef Brossa A, Papadimitriou E, Collino F, et al. Role of CD133 molecule in Wnt response and renal repair. Stem Cells Transl Med. 2018;7:283–94.CrossRef
34.
go back to reference Boivin FJ, Sarin S, Lim J, et al. Stromally expressed β-catenin modulates Wnt9b signaling in the ureteric epithelium. PLoS One. 2015;10:e0120347.CrossRef Boivin FJ, Sarin S, Lim J, et al. Stromally expressed β-catenin modulates Wnt9b signaling in the ureteric epithelium. PLoS One. 2015;10:e0120347.CrossRef
Metadata
Title
Expression of β-catenin in regenerating renal tubules of cisplatin-induced kidney failure in rats
Authors
Naomi Terada
Mohammad Rabiul Karim
Takeshi Izawa
Mitsuru Kuwamura
Jyoji Yamate
Publication date
01-12-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 6/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1583-1

Other articles of this Issue 6/2018

Clinical and Experimental Nephrology 6/2018 Go to the issue

Acknowledgment

List of referees

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.